New drug cocktail tested for Tough-to-Treat blood cancers
NCT ID NCT03132454
Summary
This early-stage study is testing the safety and best dose of a drug called palbociclib, given alone and in combination with other medications, for adults with acute leukemia that has come back or hasn't responded to previous treatments. The main goal is to find out what side effects occur and how much medicine patients can safely take. Researchers also want to see if these drug combinations show any early signs of helping control the leukemia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.